ReviewPediatric blood & cancer2025
Child and Adolescent Cancer Communication Preferences for Treatment Decision Making: A Meta-Synthesis.
Review in Pediatric blood & cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundChildren and adolescents (C&A) <18 years of age report varying cancer treatment communication preferences. The aim of this qualitative meta-synthesis was to describe C&A voices regarding their preferences for engagement in their treatment communication. This report shares their preferences specific to their involvement in cancer treatment decision-making (TDM).
methodsApplying meta-aggregation methods, a systematic search was conducted in multiple databases with no limitation to the date range. Studies included participants <18 years of age with childhood cancer using qualitative or mixed research methods, written in English. Findings were limited to C&A self-reported findings.
resultsA total of 3213 articles were identified, with 55 articles included. A total of 156 findings related to preferences for TDM were extracted from 39 studies. Three synthesized findings were identified: (1) How I participate in decisions about my cancer treatment, (2) When I do not participate in decisions about my cancer treatment, and (3) Why I participate in decisions about my cancer treatment.
conclusionsThis meta-synthesis identified how, when, and why C&A want to be involved in their cancer TDM. Their voices represent a range of preferences for involvement, from a more passive to more active role. Evidence-based practice recommendations were identified with a focus on meeting the C&A communication preferences.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.